Abeona Therapeutics Inc.

NASDAQ: ABEO · Real-Time Price · USD
5.75
-0.15 (-2.54%)
At close: Jun 27, 2025, 3:59 PM
5.75
-0.09%
After-hours: Jun 27, 2025, 05:50 PM EDT
-2.54%
Bid 5.65
Market Cap 294.41M
Revenue (ttm) n/a
Net Income (ttm) -44.19M
EPS (ttm) -0.63
PE Ratio (ttm) -9.13
Forward PE 42.61
Analyst Buy
Ask 5.88
Volume 1,013,477
Avg. Volume (20D) 1,745,311
Open 5.83
Previous Close 5.90
Day's Range 5.69 - 5.99
52-Week Range 3.93 - 7.32
Beta 1.55

About ABEO

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ABEO
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for ABEO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

Abeona Therapeutics Inc. is scheduled to release its earnings on Aug 11, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+23.77%
Abeona Therapeutics shares are trading higher afte... Unlock content with Pro Subscription
1 month ago
-0.93%
ABEO stock has given up its prior gain. Abeona Therapeutics shares were trading higher after the company announced FDA approval of ZEVASKYN for treating wounds in patients with recessive dystrophic epidermolysis bullosa.